Roundtable Discussion: Working Effectively with Challenging Samples to Achieve Maximum Multi-Omics Insight from Low Quality & Quantity Data
Time: 9:30 am
day: Conference Day Two
Details:
- Overcoming low data availability by combining omics data from different populations with the same disease and accounting for unbalanced and unnormalized data
- Upholding high quality control standards during assay development, sample collection, processing and storage to avoid damaging or wasting patient data
- Integrating protocols in preclinical and clinical development to ensure adequate sample collection and annotation
